I am not surprised if more stringent requirements are applied to more advanced clinical trials. Brakes could be applied whenever new findings are released or new concerns are addressed. Retail investors are always poorly informed like outsiders.
SRPT Duchenne Drug trial hits 5 year mark, page-50
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 122248 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 25307592 | 14 |
View Market Depth
| Last trade - 16.12pm 16/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |
Day chart unavailable